The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
NCRI 2016 | Future directions in cancer treatment: focus on tumor microenvironment
Lieping Chen, MD, PhD of Yale School of Medicine, New Haven, CT discusses future directions in cancer treatment. Thanks to scientific discoveries like PD-1/PD-L1 researchers know what to look for, which is a significant shift in approach, from looking at a whole body to focus on tumor microenvironment. Prof. Chen expects exciting discoveries in the next 5 years, but points out that science requires a lot of work and takes time, and many molecular pathways are still to be discovered. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.
